𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ERBB2 and MYC alterations in BRCA1- and BRCA2-associated cancers

✍ Scribed by José Palacios; Emiliano Honrado; Juan C. Cigudosa; Javier Benítez

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
42 KB
Volume
42
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ERBB2, TBX2, RPS6KB1, and MYC alteration
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers
✍ Camilo Adem; Cheryl L. Soderberg; Kari Hafner; Carol Reynolds; Jeffrey M. Slezak 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 1 views

Breast cancer risk is greatly increased in women who carry mutations in the BRCA1 or BRCA2 genes. Because breast cancer initiation is different between BRCA1/2 mutation carriers and women who do not carry mutations, it is possible that the mechanism of breast cancer progression is also different. Hi

Clinical management of BRCA1- and BRCA2-
Clinical management of BRCA1- and BRCA2-associated breast cancer
✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

BRCA1 and BRCA2 in Indian breast cancer
BRCA1 and BRCA2 in Indian breast cancer patients
✍ Sunita Saxena; Csilla I. Szabo; Sandrine Chopin; Laure Barjhoux; Olga Sinilnikov 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

Incidence of breast cancer in Indian women is not as high as in Western countries, nonetheless age-adjusted incidence rates (AAR) have risen from 17.9 to 24.9 per 100,000 from 1965 to 1985. Although these rates are still approximately one quarter to one third of incidence rates in North America and

Somatic genetic alterations in BRCA2-ass
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer
✍ Mika Tirkkonen; Tommi Kainu; Niklas Loman; Óskar T. Jóhannsson; Håkan Olsson; Ró 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

The genetic changes underlying the development and progression of male breast cancer are poorly understood. Germline BRCA2 mutations account for a significant part of male breast cancer, but the majority of patients lack a known inherited predisposition. We recently demonstrated that the progression